{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2019"],"condition":["Colorectal Neoplasms","Metastatic Colorectal Cancer (mCRC)"],"disease":["Colorectal Neoplasms","Metastatic Colorectal Cancer (mcrc)"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2735927"],"location":["United States"],"study_start_month":["1"],"keyword":["MCRC","Nivolumab","Checkmate-142"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)","description":"The purpose of this study is to estimate the overall survival (OS) for US participants diagnosed with metastatic colorectal cancer (mCRC) by using Flatiron Health’s individual patient level data.","dates":{"creation":"2019-01-15"},"accession":"2735927","cross_references":{"ClinicalTrials___gov":["NCT05420909"]}}